Surfactant treatment for premature lung disorders: A review of best practices in 2002

Paediatric Respiratory Reviews

Volumn 5, Issue SUPPL. A, 2004, Pages

  Morley, Colin ^a   Davis, Peter ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BERACTANT; BLES; CALFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; HEXADECANOL; KL 4; LUNG SURFACTANT; LUSUPULTIDE; OXYHEMOGLOBIN; PALMITIC ACID; PORACTANT; PUMACTANT; SINAPULTIDE; SURFACTANT TA; TRIPALMITIN; TYLOXAPOL; UNCLASSIFIED DRUG; INFRASURF; LUNG SURFACTANT EXTRACT; PHOSPHATIDYLGLYCEROL; STEROID; SURFACTANT;

AIRWAY OBSTRUCTION; BODY WEIGHT; BRADYCARDIA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHRONIC LUNG DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG FATALITY; DRUG FORMULATION; DRUG ISOLATION; DRUG METABOLISM; ELECTROENCEPHALOGRAM; HUMAN; HYPOTENSION; HYPOXIA; LENGTH OF STAY; LUNG DISEASE; LUNG DYSPLASIA; LUNG HEMORRHAGE; MENTAL DETERIORATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW; SEPSIS; SURFACE PROPERTY; BRAIN BLOOD FLOW; DISEASE EXACERBATION; INFANT; INTUBATION; TREATMENT INDICATION;

EID: 1342312414     PISSN: 15260542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(04)90054-1     Document Type: Review

References (39)

1. Soll RF. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome [review]. Cochrane Database of Systematic Reviews [computer file] 2001; CD000141.
2. Soll RF. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome [review]. Cochrane Database of Systematic Reviews (computer file] 2001; CD000144.
3. Soll RF. Surfactant treatment of the very preterm infant [review]. Biol Neonate 1998; 74(suppl 1): 35-42.
4. Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants [review]. Cochrane Database of Systematic Reviews [computer file] 2001; CD001149.
5. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants [review]. Cochrane Database of Systematic Reviews [computer file] 2001; CD000510.
6. Suresh G, Soll RF. Current surfactant use in premature infants. In: Wiswell T, Donn SM, eds., Clinics in Perinatology, Mechanical Ventilation and Exogenous Surfactant Update 28(3). Philadelphia: WB Saunders, 2001: pp. 671-694.
7. Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial. Pediatrics 1988; 82: 683-691.
8. Horbar JD, Soll RF, Sutherland JM, et al. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med 1989; 320: 959-965.
9. Bloom BT, Kattwinkel J, Hall RT, et al. Comparison of Infasurf (Calf Lung Surfactant Extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics 1997; 100: 31-38.
10. Speer CP, Gefeller O, Groneck P, et al. Randomised trial of two treatment regimes of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1995; 72: F8-F13.
11. Liechty K, Donovan E, Purohit D, et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics 1991; 88: 19-28.
12. Zola EM, Overbach AM, Gunkel JH, et al. Treatment investigational new drug experience with Survanta (Beractant). Pediatrics 1993; 91: 546-551.
13. Hamdan AH, Shaw NJ. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant. Pediatr Pulmonol 1998; 25: 191-195.
14. Sitler CG, Turnage CS, McFadden BE, et al. Pump administration of exogenous surfactant: effects on oxygenation, heart rate, and chest wall movement of premature infants. J Perinatol 1993; 13: 197-200.
15. Cowan F, Whitelaw A, Wertheim D, et al. Cerebral blood flow velocity changes after rapid administration of surfactant. Arch Dis Child 1991; 66: 1105-1109.
16. Edwards AD, McCormick DC, Roth SC, et al. Cerebral hemodynamic effects of treatment with modified natural surfactant investigated by near infrared spectroscopy. Pediatr Res 1992; 32: 532-536.
17. Hellstrom-Westas L, Bell AH, Skov L, et al. Cerebroelectrical depression following surfactant treatment in preterm neonates. Pediatrics 1992; 89: 643-647
18. Raju TN, Langenberg P. Pulmonary haemorrhage and exogenous surfactant therapy. A metaanalysis. J Pediatr 1993; 123: 603-610.
19. Kendig JW, Notter RH, Cox C, et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med 1991; 324: 865-871.
20. Dunn MS, Shennan AT, Zayack D, Possmeyer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation - a randomised controlled trial of prophylaxis versus treatment. Pediatrics 1991; 87: 377-386.
21. Egberts JE, de Winter P, Sedin G, et al. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomised trial. Pediatrics 1993; 92: 768-774.
22. Walti H, Paris-Llado J, Breart G, Couchard M, French Collaborative Multicentre Study Group. Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: a randomised, multicentre trial of prophylaxis versus rescue with multiple low doses. Acta Paediatr 1995; 84: 913-921.
23. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome [review]. Cochrane Database of Systematic Reviews [computer file] 2001; CD001456.
24. Dunn MS, Shennan AT, Possmayer F. Single- versus multiple-dose surfactant replacement therapy for neonates of 30 to 36 weeks' gestation with respiratory distress syndrome. Pediatrics 1990; 86: 564-571.
25. Speer CP, Robertson B, Curstedt T, et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: Single versus multiple doses of Curosurf. Pediatrics 1992; 89: 13-20.
26. Kattwinkel J, Bloom BT, Delmore P, et al. High versus low threshold surfactant retreatment for neonatal respiratory distress syndrome. Pediatrics 2000; 106: 282-288.
27. Zola EM, Gunkel JH, Chan KK, et al. Comparison of three dosing procedures for administration of bovine surfactant. J Pediatr 1993; 122: 453-459.
28. Soler A, Fernandez-Ruanova B, Lopez H, et al. A randomized comparison of surfactant dosing via a dual-lumen endotracheal tube in respiratory distress syndrome. The Spanish Surfactant Collaborative Group. Pediatrics 1998; 101: E4.
29. Segerer H, van Gelder W, Angenent FW, et al. Pulmonary distribution and efficacy of exogenous surfactant in lunglavaged rabbits are influenced by the instillation technique. Pediatr Res 1993; 34: 490-494.
30. Verder H, Robertson B, Griesen G, Ebbesen F, Albertsen P, Lundstrom K, Jacobsen T, The Danish-Swedish multicentre study group. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994; 331: 1051-5.
31. Verder H, Albertsen P, Ebbesen F, Griesen G, Robertson B, Bertelsen A, Agertoft L, Djernes B, Nathan E, Reinholdt J. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999; 103(2).
32. American Exosurf Neonatal Study Group 1. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. J Pediatr 1992; 120(suppl): S3-S12.
33. Ten Centre Study Group. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. BMJ 1987; 294: 991-996.
34. Long W, Corbet A, Cotton R, et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. N Engl J Med 1991; 325: 1696-1703.
35. Morley CJ, Morley, R. Follow up of premature babies treated with artificial surfactant (ALEC). Arch Dis Child 1990; 65: 667-669.
36. Survanta Multidose Study Group. Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant. J Pediatr 1994; 124: 962-967.
37. Collaborative European Multicentre Study Group. A 2-year follow-up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Eur J Pediatr 1992; 151: 372-376.
38. Dunn MS, Shennan AT, Hoskins EM, et al. Two year follow-up of infants enrolled in a randomised trial of surfactant replacement therapy for prevention of neonatal respiratory distress syndrome. Pediatrics 1998; 82: 543-547.
39. Robertson B, Curstedt T, Tubman R, et al. A two year follow-up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome: Collaborative European Multicentre, Study Group. Eur J Pediatr 1992; 151: 372-376.